Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial

The effect of alteplase on patient survival after ischaemic stroke is the subject of debate. We report the effect of intravenous alteplase on long-term survival after ischaemic stroke of participants in the Third International Stroke Trial (IST-3).In IST-3, done at 156 hospitals in 12 countries (Aus...

Full description

Bibliographic Details
Main Authors:	Berge, E, Cohen, G, Roaldsen, M, Lundström, E, Isaksson, E, Rudberg, A, Slot, K, Forbes, J, Smith, J, Drever, J, Wardlaw, J, Lindley, R, Sandercock, P, Whiteley, W
Format:	Journal article
Language:	English
Published:	Elsevier 2016

Similar Items

The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke
by: Cantisani Teresa, et al.
Published: (2008-06-01)

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
by: Sandercock Peter, et al.
Published: (2011-11-01)

Hyperdense artery sign, symptomatic infarct swelling and effect of alteplase in acute ischaemic stroke
by: Ming Liu, et al.

Normal Appearing Ischaemic Brain Tissue on CT and Outcome After Intravenous Alteplase
by: Grant Mair, et al.
Published: (2022-06-01)

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
by: Sandercock, P, et al.
Published: (2012)

Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis
by: Whiteley, W, et al.
Published: (2016)

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS
by: P. Sandercock, et al.
Published: (2002-01-01)

Alteplase for the treatment of acute ischaemic stroke: a single technology appraisal
by: M Lloyd Jones, et al.
Published: (2009-09-01)

Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.
by: Lees, K, et al.
Published: (2016)

Imaging perfusion deficits, arterial patency and thrombolysis safety and efficacy in acute ischaemic stroke. An observational study of the effect of advanced imaging methods in The Third International Stroke Trial (IST-3), a randomised controlled trial
by: Joanna M Wardlaw, et al.
Published: (2014-07-01)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.
by: Emberson, J, et al.
Published: (2014)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials
by: Emberson, J, et al.
Published: (2014)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
by: Yi Dong, et al.

What are the risks of intracerebral haemorrhage due to alteplase after acute ischaemic stroke? Results from an individual patient data meta-analysis of randomised trials
by: Emberson, J, et al.
Published: (2016)

Endovascular treatment with or without intravenous alteplase for acute ischaemic stroke due to basilar artery occlusion
by: Liping Liu, et al.
Published: (2022-06-01)

Predicting risks and benefits of treatment with aspirin in the acute stage of ischaemic stroke: an individual patient data meta-analysis of 39,166 patients in 3 large randomised controlled trials
by: Whiteley, W, et al.
Published: (2013)

Effects of alteplase for acute stroke according to criteria defining the EU and US marketing authorizations: individual-patient-data meta-analysis of randomized trials
by: Hacke, W, et al.
Published: (2017)

Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
by: Yongjun Wang, et al.

The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
by: Sandercock, P, et al.
Published: (1997)

Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study.
by: Sylaja, P, et al.
Published: (2006)

Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial
by: Dar Dowlatshahi, et al.

Reteplase versus alteplase for acute ischaemic stroke within 4.5 hours (RAISE): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint, controlled phase 3 non-inferiority trial
by: Yongjun Wang, et al.

Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study
by: Huisheng Chen, et al.

Effects of alteplase in the treatment of acute ischemic stroke
by: Yayan J
Published: (2012-09-01)

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial
by: Anderson, C, et al.
Published: (2019)

Who will benefit more from low-dose alteplase in acute ischemic stroke?
by: Wang, X, et al.
Published: (2019)

Low versus standard dose intravenous alteplase in acute ischemic stroke
by: Woodward, M, et al.
Published: (2016)

Effectiveness of alteplase in the very elderly after acute ischemic stroke
by: Yayan J
Published: (2013-07-01)

Reactions to alteplase in patients with acute thrombotic stroke - Reply
by: Hill, MD, et al.
Published: (2000)

High early risk of stroke after a first transient ischaemic attack
by: Lovett, J, et al.
Published: (2003)

Lingual angioedema with macroglossia during the treatment of acute ischemic stroke with alteplase
by: Yayan J
Published: (2012-02-01)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
by: Nishita Singh, et al.
Published: (2023-01-01)

Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study
by: Ying Zhou, et al.

"Englisch ist wichtig, Chinesisch ist nützlich in Zukunft, Deutsch ist schwierig." Argumente für den L3-Unterricht an japanischen Hochschulen
by: Barbara Klema, et al.
Published: (2015-05-01)

Alteplase Causing Cardiac Tamponade after Recent Cardiac Pacemaker Placement
by: Corey J. Warf, et al.
Published: (2018-08-01)

Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
by: Vicky Chalos, et al.
Published: (2019-06-01)

Was ist "wissenschaftliche" Politikberatung?
by: J. Luhmann, et al.
Published: (2003-04-01)

Was ist Stadt? Was ist Kritik?
by: Nikolai Roskamm, et al.
Published: (2022-06-01)

Symptomatic hemorrhage after alteplase therapy not due to silent ischemia
by: Barber Philip A, et al.
Published: (2001-01-01)

Switching from Alteplase to Tenecteplase: Time to AcT?
by: Eric D. Goldstein, et al.
Published: (2022-09-01)